Skip to main content
Daniel Rifkin, MD, Pediatric Pulmonology, Hershey, PA

DanielSRifkinMD

Pediatric Pulmonology Hershey, PA

Assistant Professor, Pediatrics, Pennsylvania State University College of Medicine

Are you Dr. Rifkin?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 56 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    500 University Dr
    Hershey, PA 17033
    Phone+1 800-233-4082

Summary

  • Dr. Daniel Rifkin, MD is a pediatric pulmonologist in Hershey, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Arkansas, and New Jersey. He is affiliated with Penn State Milton S. Hershey Medical Center and Penn State Health Holy Spirit Medical Center.

Education & Training

  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaFellowship, Pediatric Pulmonology, 1998 - 2000
  • Tower Health
    Tower HealthFellowship, Pediatric Pulmonology, 1997 - 1998
  • University of Maryland
    University of MarylandResidency, Pediatrics, 1994 - 1997
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1994

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1997 - 2024
  • AR State Medical License
    AR State Medical License 2000 - 2009
  • NJ State Medical License
    NJ State Medical License 1999 - 2001
  • American Board of Pediatrics Pediatric Pulmonology

Publications & Presentations

PubMed

Press Mentions

  • Transglutaminase 2: A Novel Therapeutic Target for Idiopathic Pulmonary Fibrosis Using Selective Small Molecule Inhibitors
    Transglutaminase 2: A Novel Therapeutic Target for Idiopathic Pulmonary Fibrosis Using Selective Small Molecule InhibitorsJanuary 21st, 2021